Ashley Cannon, Ph.D.
Affiliations: | 2012 | Molecular Neuroscience | College of Medicine - Mayo Clinic |
Area:
Neuropathology of aging, dementia and parkinsonismGoogle:
"Ashley Cannon"Mean distance: 18.5 (cluster 32) | S | N | B | C | P |
Parents
Sign in to add mentor| Jada Lewis | grad student | 2007-2010 | Mayo Clinic Jacksonville | |
| Dennis W. Dickson | grad student | 2012 | College of Medicine - Mayo Clinic | |
| (Neuronal sensitivity to TDP-43 expression: Insight from an inducible TDP-43 mouse model.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Assia Batzir N, Kishor Bhagwat P, Larson A, et al. (2019) Recurrent Arginine Substitutions in the ACTG2 Gene are the Primary Driver of Disease Burden and Severity in Visceral Myopathy. Human Mutation |
| Murray ME, Lowe VJ, Graff-Radford NR, et al. (2015) Clinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer's disease spectrum. Brain : a Journal of Neurology. 138: 1370-81 |
| Cannon A, Bieniek KF, Lin WL, et al. (2014) Concurrent variably protease-sensitive prionopathy and amyotrophic lateral sclerosis. Acta Neuropathologica. 128: 313-5 |
| Murray ME, Cannon A, Graff-Radford NR, et al. (2014) Differential clinicopathologic and genetic features of late-onset amnestic dementias. Acta Neuropathologica. 128: 411-21 |
| D'Alton S, Altshuler M, Cannon A, et al. (2014) Divergent phenotypes in mutant TDP-43 transgenic mice highlight potential confounds in TDP-43 transgenic modeling. Plos One. 9: e86513 |
| Rutherford NJ, Lewis J, Clippinger AK, et al. (2013) Unbiased screen reveals ubiquilin-1 and -2 highly associated with huntingtin inclusions. Brain Research. 1524: 62-73 |
| Clippinger AK, D'Alton S, Lin WL, et al. (2013) Robust cytoplasmic accumulation of phosphorylated TDP-43 in transgenic models of tauopathy. Acta Neuropathologica. 126: 39-50 |
| Cannon A, Fujioka S, Rutherford NJ, et al. (2013) Clinicopathologic variability of the GRN A9D mutation, including amyotrophic lateral sclerosis. Neurology. 80: 1771-7 |
| Cannon A, Yang B, Knight J, et al. (2012) Neuronal sensitivity to TDP-43 overexpression is dependent on timing of induction. Acta Neuropathologica. 123: 807-23 |
| Bailey R, Cannon A, Melrose H, et al. (2012) P1-195: LRRK2 modulation of neuropathology in a mouse model of tauopathy Alzheimer's & Dementia. 8: P175-P175 |